论文部分内容阅读
自从１９９２年国内免疫核糖核酸（ｉＲＮＡ）首次批准生产以后，曾一度出现过ｉＲＮＡ的热潮。国内众多厂家纷纷投产，ｉＲＮＡ的种类也迅速增多，除有抗乙肝ｉＲＮＡＲ抗甲肝ｉＲＮＡ外，还有多种抗恶性肿瘤的ｉＲＮＡ。ｉＲＮＡ的临床使用量也迅速增长。但过了个到两年，ｉ
Since the initial approval of the domestic immunological ribonucleic acid (iRNA) in 1992, an upsurge in iRNA occurred. Many domestic manufacturers have put into operation, the types of iRNA also increased rapidly, in addition to anti-hepatitis B iRNAR anti-hepatitis A iRNA, there are a variety of anti-cancer iRNA. The clinical use of iRNA has also increased rapidly. But after a year or two, i